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The current concept is that Tsc-deficient cells are sensitized to apoptosis due to the inhibition of Akt activity by
the negative feedback mechanism induced by the hyperactive mTORC1. Unexpectedly, however, we found that
Tsc1/2-deficient cells exhibit increased resistance to serum deprivation-induced apoptosis. mTORC1 hyperactivity
contributes to the apoptotic resistance of serum-deprived Tsc1/2-deficient cells in part by increasing the growth
factor-independent expression of hexokinase II (HKII) and GLUT1. mTORC1-mediated increase in hypoxia-
inducible factor 1 (HIF1) abundance, which occurs in the absence of serum in normoxic Tsc2-deficient cells,
contributes to these changes. Increased HIF1 abundance in these cells is attributed to both an increased level and
the sustained translation of HIF1 mRNA. Sustained glycogen synthase kinase 3 inhibition and Mcl-1 expression
also contribute to the apoptotic resistance of Tsc2-deficient cells to serum deprivation. The inhibition of mTORC1
activity by either rapamycin or Raptor knockdown cannot resensitize these cells to serum deprivation-induced
apoptosis because of elevated Akt activity that is an indirect consequence of mTORC1 inhibition. However, the
increased HIF1 abundance and the maintenance of Mcl-1 protein expression in serum-deprived Tsc2/ cells are
dependent largely on the hyperactive eIF4E in these cells. Consistently, the reduction of eIF4E levels abrogates the
resistance of Tsc2/ cells to serum deprivation-induced apoptosis.
Growth factors are obligatory for the survival of mammalian
cells. The evolutionarily conserved kinase Akt has emerged as
the predominant and indispensable mediator of the ability of
growth factors to promote cell survival in mammalian cells
(reviewed in reference 9). Akt promotes cell survival by mul-
tiple mechanisms, including key roles in regulating cellular
energy metabolism. Akt maintains mitochondrial integrity and
inhibits apoptosis at least in part through effects on mitochon-
drial hexokinases and their functionally coupled facilitated glu-
cose transporters (reviewed in reference 18). One of the most
crucial functions of Akt involves the activation of the mamma-
lian target of rapamycin complex 1 (mTORC1), which inte-
grates growth factor signaling with nutritional cues and syn-
chronizes these upstream signals with the downstream
stimulation of cell growth and proliferation (reviewed in ref-
erence 1). Akt activates mTORC1 in part by inhibiting the
heterodimeric tuberous sclerosis complex (Tsc1/Tsc2). Tsc2
(or tuberin) functions as a GTPase-activating protein (GAP)
to specifically inhibit the small GTPase Rheb, which activates
mTORC1. The formation of a functional heterodimeric com-
plex between Tsc2 and Tsc1 (or hamartin) is required for
mTORC1 inhibition. As such, the disruption of the expression
or function of either Tsc1 or Tsc2 is sufficient to activate
mTORC1. Mammalian cells have evolved a negative feedback
mechanism between mTORC1 and Akt to maintain an op-
timal balance between their activities. When Akt activates
mTORC1, it initiates a negative feedback loop that serves to
attenuate Akt activity. As such, mTORC1 serves as both an
upstream and a downstream effector of Akt signaling. The loss
of a functional Tsc1/Tsc2 complex disrupts this delicate bal-
ance, resulting in mTORC1 hyperactivity, which greatly re-
duces Akt activation (reviewed in reference 1). This is relevant
to the heritable development of tuberous sclerosis in humans,
which is caused by the mutational inactivation of either the
TSC1 or TSC2 gene, leading to benign hamartoma formation
and growth in a variety of organs (11).
It is widely appreciated that low basal Akt activity renders
Tsc1/2-deficient cells more sensitive to proapoptotic stimuli (4,
19). Unexpectedly, however, we found that both Tsc1 and Tsc2
null cells exhibit increased apoptotic resistance to growth fac-
tor withdrawal despite greatly reduced Akt activity relative to
that of their wild-type counterparts. This implies that Tsc1/2
deficiency promotes or unmasks potent antiapoptotic mecha-
nisms that reduce mammalian cell dependence upon growth
factors and Akt for survival. Further investigation has uncov-
ered a critical role for mTORC1 in promoting cell survival in
the absence of growth factors.
Trophic growth factors found in serum play a pivotal role in
the cellular uptake and utilization of glucose, and serum with-
drawal results in attenuated glucose metabolism. The mainte-
nance of glucose utilization by the overexpression of the rate-
limiting glycolytic enzyme hexokinase and its functionally
coupled facilitative glucose transporters maintains cell survival
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in the absence of growth factors (reviewed in reference 18).
We found that serum deprivation markedly increased both
hexokinase II (HKII) and GLUT1 abundance in Tsc2-deficient
cells, and the knockdown of HKII and GLUT1 increased the
apoptotic susceptibility of these cells to serum deprivation. The
elevated expression of HKII and GLUT1 is mediated by hy-
poxia-inducible factor 1 (HIF1) protein, which is markedly
induced by mTORC1 in serum-deprived Tsc2/ cells.
In addition to increased HKII and GLUT1 expression,
Tsc2/ cells display the sustained inhibition of glycogen syn-
thase kinase 3 (GSK3) activity and stable Mcl-1 abundance
following serum withdrawal, which also contribute to their
apoptotic resistance under these conditions. Mcl-1 abundance,
which normally declines following serum deprivation, is sus-
tained in Tsc2/ cells by the constitutive inhibition of GSK3
and the activation of eIF4E.
MATERIALS AND METHODS
Cells and retroviruses. All cells were cultured in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS; Gemini
Bio-Products), 100 IU/ml penicillin, and 100 g/ml streptomycin. The Tsc2/
murine embryonic fibroblasts (MEFs) and Tsc2/ MEFs (gifts from D. J.
Kwiatkowski) were derived from p53/ mouse embryos. The Tsc1/ MEFs
and Tsc1/ MEFs were obtained as primary cells containing wild-type p53 (gifts
from D. J. Kwiatkowski) and were immortalized by infecting them with a retro-
virus (pBabePuro-GSE56) expressing dominant-negative p53 (20).
All of the retroviruses used were generated by the transient transfection of the
retroviral vectors into Phoenix ecotropic packaging cell lines, and then the
retrovirus-containing culture medium was harvested. The retroviruses were used
to infect cells in the presence of 8 g/ml polybrene for 24 h. The pBabe(GFP)-
BAD and pBabe(GFP)-BAD S112,136A plasmids were described before (10).
The retroviral vector pLPCX-Tsc2 was constructed by inserting rat Tsc2 into the
NotI site of pLPCX. Retroviruses encoding either pLPCX or pLPCX-Tsc2 were
made and used to infect Tsc2/ p53/ MEFs, which then were selected using
puromycin (3.5 g/ml), resulting in the generation of Tsc2//pLPCX MEFs and
Tsc2//pLPCX-Tsc2 MEFs.
RNA interference-mediated gene knockdown. The short interfering RNAs
(siRNAs) were transfected into the Tsc2/ MEFs using Lipofectamine 2000
transfection reagent. GLUT1 knockdown was achieved by transfecting cells with
GLUT1 Stealth siRNA from Invitrogen (GGCGGAACUCCAUGCUGAUGA
UGAA); the corresponding negative control used was Stealth negative control
medium GC siRNA (Invitrogen). Mcl-1 knockdown was achieved by transfecting
cells with Mcl-1 SMARTpool siRNA from Dharmacon. HIF1 knockdown was
achieved by transfecting cells with HIF1A ON-TARGETplus SMARTpool
siRNA from Dharmacon. For short hairpin RNA (shRNA)-mediated gene
knockdown, the shRNAs were cloned into the lentiviral vector pLenti6/BLOCK-
iT-DEST (Invitrogen), and lentiviruses encoding these vectors were generated.
The lentiviruses were used to infect Tsc2/ MEFs in the presence of polybrene
(8 g/ml) for about 8 h. After about 48 h of infection, the cells were selected
using Blasticidin (20 g/ml for 3 days). The Raptor and LacZ shRNA sequences
were described before (20). The sequences of the HKII shRNA are 5CACCG
CATATGATCGCCTGCTTATTCGAAAATAAGCAGGCGATCATATGC 3
(top strand) and 5AAAAGCATATGATCGCCTGCTTATTTTCGAATAAGC
AGGCGATCATATGC 3 (bottom strand). The sequences of the Akt1 shRNA
are 5CACCGCTACTTCCTCCTCAAGAATGTTCAAGAGACATTCTTGA
GGAGGAAGTAGC 3 (top strand) and 5AAAAGCTACTTCCTCCTCAAG
AATGTCTCTTGAACATTCTTGAGGAGGAAGTAGC 3 (bottom strand).
The LacZ-targeting shRNA was used as a negative control for the Raptor-,
HKII-, and Akt1-targeting shRNAs.
Antisense knockdown of eIF4E. To reduce eIF4E expression, eIF4E antisense
oligonucleotides (ASO) with a phosphorothioate backbone and flanking bases
modified with a methoxyethyl group at the 2 position of the sugar were obtained
from Eli Lilly and were used as previously described (6). Cells were washed twice
with phosphate-buffered saline (PBS) 24 and 48 h posttransfection, and cells
were subjected to serum withdrawal for 72 h. Cells then were lysed for protein
isolation and immunoblotting or fixed with formaldehyde and subjected to 4,6-
diamidino-2-phenylindole (DAPI) staining for apoptosis determination.
Apoptosis assay. Cells were plated at low density (50,000 cells/well of a
6-well plate) and allowed to grow overnight before being subjected to treatments
that induce apoptosis. At the end of the apoptosis induction period, the cells
were fixed by the direct addition of formaldehyde (final concentration, 12%) to
the culture medium. After overnight fixation, the cells were washed with PBS,
stained with DAPI (1 g/ml for 6 min), and then left in PBS. The cells were
visualized using fluorescence microscopy, and cells with the condensed and/or
fragmented chromatin that is characteristic of apoptosis were counted as apop-
totic.
Immunoblot analysis. For immunoblot analysis, the cells were plated at low
density (125,000 cells/6-cm plate) and allowed to grow for 24 h before the
application of the various experimental conditions. Afterwards, the cells were
harvested, and cell extracts were made using ice-cold lysis buffer (20 mM
HEPES, 1% Triton X-100, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 10 mM
sodium pyrophosphate, 100 mM NaF, 5 mM iodoacetic acid, 20 nM okadaic acid,
0.2 mM phenylmethylsulfonyl fluoride, and Complete protease inhibitor cocktail
[Roche Diagnostics]). The extracts were run on sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis, transferred to a polyvinyl difluoride membrane,
and probed with the following antibodies: anti-Raptor (a gift from N. Sonen-
berg), anti-phospho-p70 S6 kinase T389 (Cell Signaling), anti-p70 S6 kinase (Cell
Signaling), anti-phospho-Akt S473 (Cell Signaling), anti-Akt (Cell Signaling),
anti-Akt1 pH domain (Upstate), antiactin (Sigma), anti-BAD (Cell Signaling),
anti-phospho-BAD S112 (Cell Signaling), anti-phospho-BAD S136 (Cell Signal-
ing), anti-GLUT1 (Alpha Diagnostic), anti-Mcl-1 (Santa Cruz), anti-HKII (a gift
from R. B. Robey), anti-GSK3 (QCB), anti-phospho-GSK3 Ser9 (Cell Sig-
naling), HIF1 (Novus), anti-eIF4E (obtained from N. Sonenebrg), and anti-
tubulin (Sigma). The quantification of Western blots was done using ImageJ
software.
Real-time reverse transcription-PCR (RT-PCR). Total RNA was isolated
from cells and reverse transcribed into cDNA, which then was subjected to a
real-time PCR using the iQ SYBR green supermix reagent (Bio-Rad). The
GLUT1 PCR primers used were 5CAGTTCGGCTATAACACTGGTG3 and
5GCCCCCGACAGAGAAGATG3. The HKII PCR primers used were 5TG
ATCGCCTGCTTATTCACGG3 and 5AACCGCCTAGAAATCTCCAGA3.
The HIF1 PCR primers used were 5ACCTTCATCGGAAACTCCAAAG3
and 5ACTGTTAGGCTCAGGTGAACT3.
BrdU labeling. To determine actively replicating cells after serum withdrawal
or upon serum stimulation, cells were incubated in the absence of serum for 48 h
and then either fixed or rinsed twice with PBS and stimulated with 10% FBS for
24 h before fixation. In both conditions, 3 h prior to fixation, cells were incubated
with 3 g/ml bromodeoxyuridine (BrdU) and stained for incorporated BrdU.
Briefly, cells were washed with PBS, fixed for 10 min in 70% ice-cold ethanol at
20°C, and washed. The DNA then was denatured to single strands for the
antibody to bind incorporated BrdU. This was done by incubating the cells in 2
M HCl–0.5% Triton X-100 for 1 h (at room temperature). Denaturation was
stopped by washing the cells with 0.1 M sodium borate and then with PBS. The
cells subsequently were incubated overnight at 4°C with a monoclonal antibody
against BrdU (Dako) and fluorescein isothiocyanate-conjugated secondary anti-
body for 2 h (room temperature). Data are expressed as the percentages of cells
positive for BrdU staining compared to the total cell number determined by
DAPI staining.
RESULTS
Tsc1/2-deficient MEFs are highly resistant to apoptosis in-
duced by growth factor withdrawal but are hypersensitive to
other proapoptotic stimuli. Because Tsc1/2-deficient cells dis-
play diminished Akt activity, it is expected that they are hyper-
sensitive to apoptosis induced by growth factor withdrawal.
However, we found that despite reduced Akt activity, Tsc2/
MEFs are markedly more resistant to serum deprivation-in-
duced apoptosis than their Tsc2/ counterparts (Fig. 1A). To
address the specificity of this observation, Tsc2/ MEFs were
stably transduced with a Tsc2-expressing retrovirus to generate
a polyclonal Tsc2-reconstituted cell line (designated Tsc2//
Tsc2 MEFs) as previously described (20). A control polyclonal
cell line transduced by the corresponding empty vector also
was generated in parallel. As expected, the Tsc2 expression in
Tsc2/ cells restored Akt activity (Fig. 1B). As shown in Fig.
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1C, Tsc2//Tsc2 MEFs were dramatically more sensitive to
apoptosis induced by serum withdrawal than control Tsc2/
MEFs. Furthermore, after 48 h of serum deprivation, the
Tsc2/ cells completely recovered when they were reexposed
to serum and continued to proliferate as measured by BrdU
incorporation (Fig. 1D and E).
These findings validate the notion that Tsc2/ MEFs are
highly resistant to apoptosis induced by growth factor with-
FIG. 1. Tsc2/ MEFs are resistant to serum deprivation-induced apoptosis but hypersensitive to other apoptotic stimuli in the presence of serum.
(A) Apoptosis induced by the serum deprivation of Tsc2/ or Tsc2/ MEFs. The apoptosis was measured after 7, 24, or 48 h of serum deprivation.
Data represent the means  standard errors of the means from three independent experiments.  and , P 	 0.05 and P 	 0.001, respectively,
compared to results for Tsc2/ MEFs. ## and ###, P 	 0.01 and P 	 0.001, respectively, compared to results at 7 h. † and ††, P 	 0.05 and P 	
0.01, respectively, compared to results at 24 h. (B) Immunoblot showing mTORC1 activity and Akt activity. Tsc2/ MEFs (lane 1), Tsc2/ MEFs (lanes
2, 4, and 6), and Tsc2/ MEFs reconstituted with Tsc2 (lanes 3, 5, and 7) were cultured in the presence (lanes 1 to 3) or absence of 10% serum (lanes
4 to 7) for 18 h and then were left untreated (lanes 4 and 5) or restimulated with 10% serum for 1 h (lanes 6 and 7). Lysates of these cells were analyzed
by immunoblotting using antibodies specific for Akt phosphorylation (p-Akt) on Ser473 (an indicator of Akt activity), total Akt, p70S6 kinase
phosphorylation on Thr389 (p-S6K1; an indicator of mTORC1 activity), total p70S6 kinase, and actin. (C) Apoptosis induced by the serum deprivation
of Tsc2/ MEFs or reconstituted Tsc2/ (Tsc2//Tsc2) MEFs. The apoptosis was measured after 7, 24, 34, or 48 h of serum deprivation. Data
represent the means  standard errors of the means of three independent experiments. , P 	 0.001 compared to results for Tsc2/ cells. ## and
###, P 	 0.01 and P 	 0.001, respectively, compared to results at 7 h. †, P 	 0.05 compared to results at 24 h. (D) Apoptosis induced by the serum
deprivation of Tsc2/ MEFs or reconstituted Tsc2/ (Tsc2//Tsc2) MEFs. The cells were incubated in the absence of FBS for 48 h and then were
fixed for apoptosis determination or rinsed twice with PBS and incubated with 10% FBS for 24 h. The apoptosis was measured after 48 h of serum
deprivation or 48 h of serum deprivation, followed by 24 h of serum stimulation. Data represent the means  standard errors of the means from three
independent experiments. , P 	 0.001 compared to results for Tsc2/ MEFs. # and ##, P 	 0.05 and P 	 0.01, respectively, compared to results
at 48 h with 0% FBS. (E) Proliferation rate of Tsc2/ MEFs or reconstituted Tsc2/ (Tsc2//Tsc2) MEFs. The cells were incubated as described for
panel D, and the proliferation rate was measured by labeling cells for 3 h with BrdU prior to fixation and staining. BrdU incorporation was carried out
as described in Materials and Methods and measured by counting at least 150 cells from at least five fields in triplicate plates. Data represent the means
 standard errors of the means from three independent experiments. , P 	 0.001 compared to results for Tsc2/ MEFs. #, P 	 0.05 compared to
results at 48 h with 0% FBS. (F) Apoptosis induced by etoposide treatment of Tsc2/ and Tsc2//Tsc2 MEFs. Data represent the means  standard
errors of the means from three independent experiments. , P 	 0.001 compared to results for Tsc2//Tsc2. The cells were exposed to 75 M
etoposide in the presence of 10% serum for 24 h. (G) Apoptosis induced by the staurosporine treatment of Tsc2/ MEFs or Tsc2//Tsc2 MEFs. The
cells were exposed to 100 nM staurosporine in the presence of 10% serum for 7 h. Data represent the means  standard errors of the means from three
independent experiments. , P 	 0.001 compared to results for Tsc2//Tsc2 MEFs. Apoptosis induced by the glucose deprivation of Tsc2/ MEFs
or Tsc2//Tsc2 MEFs. (H) Cells were subjected to glucose deprivation in the presence or in the absence of serum for 48 h, and then apoptosis was
assessed by DAPI staining. Data represent the means  standard errors of the means from three independent experiments. , P 	 0.01 compared to
results for 10% FBS; ###, P 	 0.001 compared to results for Tsc2/ MEFs. (I) Apoptosis induced by etoposide treatment of Tsc2/ and reconstituted
Tsc2//Tsc2 MEFs. The cells were treated with etoposide (75 M) for 24 h in the absence of FBS. Data represent the means  standard errors of the
means from three independent experiments. (J) Apoptosis induced by the staurosporine treatment of Tsc2/ MEFs or Tsc2//Tsc2 MEFs. The cells
were exposed to 100 nM staurosporine in the absence of serum for 7 h. Data represent the means  standard errors of the means from three independent
experiments.
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drawal. Because it had been shown previously that Tsc2/
cells are hypersensitive to apoptosis induced by etoposide and
other proapoptotic stimuli in the presence of serum (4, 19), we
also examined the sensitivity of Tsc2/ cells to apoptotic
stimuli other than growth factor deprivation. We confirmed
that in the presence of serum, Tsc2/ MEFs are more sensi-
tive to apoptosis induced by etoposide, staurosporine, and glu-
cose withdrawal than Tsc2//Tsc2 MEFs (Fig. 1F, G, and H).
Notably, in the absence of serum, Tsc2/ MEFs were not
more sensitive to etoposide and staurosporine than Tsc2//
Tsc2 MEFs (Fig. 1I and J). The results also were confirmed
when apoptosis was quantified by annexin V/propidium iodide
staining (data not shown). The apoptotic sensitivities of
Tsc1/ and Tsc1/ MEFs in response to different proapop-
totic stimuli also were compared, and Tsc1 deficiency was
found to result in changes indistinguishable from those ob-
served in Tsc2/ MEFs (Fig. 2). Collectively, these results
show that despite diminished Akt activity, which is a major
downstream effector of growth factor-mediated cell survival,
Tsc1/2-deficient cells display a survival pathway that promotes
apoptotic resistance to growth factor withdrawal. We therefore
focused our attention upon the identification of this unknown
prosurvival pathway that is activated in Tsc1/2-deficient cells.
Inhibition of mTORC1 failed to overcome the resistance of
Tsc2/ MEFs to serum withdrawal as a consequence of indi-
rect Akt activation. To determine whether increased mTORC1
signaling in Tsc2/ MEFs is responsible for the apoptotic resis-
tance to growth factor withdrawal, these cells were subjected to
serum withdrawal for 48 h in both the absence and presence of
rapamycin. No significant effect of rapamycin was observed after
48 h of serum deprivation (Fig. 3A). Moreover, Raptor knock-
down, which markedly decreased mTORC1 activity (Fig. 3B), did
not increase, but rather decreased, the apoptotic susceptibility of
Tsc2/ MEFs to serum deprivation (Fig. 3A). These results
seem to suggest that mTORC1 activity does not directly contrib-
ute to the mechanism by which Tsc2/ MEFs resist apoptosis
due to serum withdrawal. However, the inhibition of mTORC1
leads to an increase in Akt activity (Fig. 3B). The increase in Akt
activity by rapamycin or by Raptor knockdown correlates with
their relative effect on the sensitivity of Tsc2/ cells to growth
factor withdrawal-induced apoptosis and could explain the in-
creased resistance induced by Raptor knockdown. Therefore,
these results raised the possibility that the hyperactivated
mTORC1 in Tsc2/ cells mediate the resistance of these cells to
growth factor withdrawal-induced apoptosis, but mTORC1 inhi-
bition is unable to reverse this apoptotic resistance because of the
associated increase in Akt activity that results from disrupted
feedback inhibition.
To test this possibility, we also examined responses to the
addition of the selective phosphatidylinositol 3-kinase antago-
nist LY294002. LY294002 completely abolished rapamycin-
induced Akt activation (Fig. 3C), so Tsc2/ MEFs also were
examined for apoptotic susceptibility to serum withdrawal in
the presence of rapamycin alone or in combination with
LY294002. Whereas rapamycin alone only marginally, and not
significantly, affected apoptosis, the combination of rapamycin
and LY294002 markedly sensitized Tsc2/ MEFs to apoptosis
induced by serum withdrawal (Fig. 3C and D). Likewise, the
knockdown of Raptor in combination with LY294002 mark-
edly sensitized Tsc2/ MEFs to apoptosis induced by serum
withdrawal (Fig. 3D). To further substantiate these results,
shRNAs specifically targeting Akt1, which is the predominant
Akt isoform expressed in MEFs (20), or LacZ (control) were
stably introduced into Tsc2/ MEFs by lentiviral transduction
(designated Tsc2//Akt1 and Tsc2//LacZ, respectively).
Akt1 knockdown predictably and significantly decreased total
Akt activity, and rapamycin failed to increase total Akt activity
above the level observed in untreated control cells (Fig. 3E).
When subjected to serum withdrawal in the presence of rapa-
mycin, Tsc2//Akt1 shRNA cells underwent robust apoptosis
(Fig. 3F). This is consistent with the notion that rapamycin’s
inability to abrogate the apoptotic resistance of Tsc2/ cells
to growth factor withdrawal is mediated by Akt activation. In
contrast, control Tsc2//LacZ shRNA cells remained rela-
tively resistant to apoptosis.
Given the hypersensitivity of Tsc2/ cells to etoposide-in-
duced apoptosis and the ability of Akt to protect against etopo-
side-mediated cell death, we predicted that mTORC1 inhibition
in Tsc2/ cells would increase Akt activation and hence their
apoptotic resistance to etoposide. Indeed, we found that rapamy-
cin increased Tsc2/ cell resistance to etoposide-induced apop-
tosis (Fig. 3G). In summary, these results strongly suggest that
mTORC1 hyperactivation can account for the resistance of
Tsc2/ cells to growth factor withdrawal. This was not, however,
directly demonstrable by mTORC1 inhibition due to the resulting
activation of Akt. We therefore searched for downstream effec-
tors of mTORC1 that could mediate resistance to apoptosis in-
duced by growth factor withdrawal.
FIG. 2. Tsc1/ MEFs are resistant to serum deprivation-induced
apoptosis but hypersensitive to other apoptotic stimuli in the presence
of serum. (A) Apoptosis induced by the serum deprivation of Tsc1/
(f) or Tsc1/ () MEFs. The apoptosis was measured after 7, 24, or
48 h of serum deprivation. Data represent the means  standard errors
of the means from three independent experiments. , P 	 0.001
compared to results for Tsc1/ MEFs. #, ##, and ###, P 	 0.05,
P 	 0.01, and P 	 0.001, respectively, compared to results at 7 h. †, P 	
0.05 compared to results at 24 h. (B) Apoptosis induced by etoposide
treatment of Tsc1/ or Tsc1/ MEFs. The cells were exposed to 75
M etoposide in the presence of 10% serum for 24 h. , P 	 0.01
compared to results for Tsc1/ MEFs. (C) Apoptosis induced by the
staurosporine treatment of Tsc1/ or Tsc1/ MEFs. The cells were
exposed to 100 nM staurosporine in the presence of 10% serum for 6 h.
, P 	 0.001 compared to results for Tsc1/ MEFs.
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The resistance of Tsc2/ MEFs to serum withdrawal-in-
duced apoptosis is independent of BAD phosphorylation. It
was reported previously that the inhibition of S6K1 by the
overexpression of Tsc2 activates the proapoptotic protein
BAD, because S6K1 can inhibit BAD activity by the phosphor-
ylation of Ser136 (3). In addition to phosphorylation on this
site, BAD also can be inhibited by phosphorylation on Ser112
(7). We sought to examine the phosphorylation status of BAD
FIG. 3. Inhibition of mTORC1 activity by rapamycin (RAPA) or the knockdown of Raptor in Tsc2/ MEFs could not abrogate resistance to serum
deprivation-induced apoptosis because of the elevated Akt activity. (A) Effect of mTORC1 inhibition on apoptosis triggered by serum deprivation.
Tsc2/ MEFs in the absence or presence of 20 nM rapamycin, Tsc2/ MEFs expressing LacZ shRNA (control) or Raptor shRNA, and Tsc2//Tsc2
MEFs were subjected to serum deprivation. Apoptosis was quantified after 48 h of serum deprivation. Data represent the means  standard errors of
the means from three independent experiments. , P 	 0.05 compared to results for Tsc2/ MEFs; # and ##, P 	 0.05 and P 	 0.01, respectively,
compared to results for Tsc2//Tsc2 MEFs. (B) Immunoblot showing mTORC1 activity and Akt activity upon rapamycin treatment or Raptor
knockdown. Tsc2/ MEFs in the absence or presence of rapamycin (20 nM) and Tsc2/ MEFs expressing LacZ shRNA (control) or Raptor shRNA
were cultured in the presence or absence of 10% serum for 24 h. Lysates of these cells were analyzed by immunoblotting using antibodies specific for
Raptor, Akt phosphorylation on Ser473 (p-Akt; an indicator of Akt activity), total Akt, p70S6 kinase phosphorylation on Thr389 (p-S6K1; an indicator
of mTORC1 activity), total p70S6 kinase, and actin. (C) LY294002 diminished the increase in Akt activity induced by rapamycin. Tsc2/ MEFs without
treatment, in the presence of rapamycin (20 nM), or in the combined presence of rapamycin (20 nM) and LY294002 (7.5 M) were subjected to serum
deprivation for 24 h. Lysates of these cells were analyzed by immunoblotting using antibodies specific for Akt phosphorylation on Ser473 (an indicator
of Akt activity), total Akt, p70S6 kinase phosphorylation on Thr389 (an indicator of mTORC1 activity), total p70S6 kinase, and actin. (D) Tsc2/ MEFs
expressing LacZ shRNA (control) without treatment, in the presence of rapamycin (20 nM), in the presence of LY294002 (7.5 M), in the combined
presence of rapamycin and LY294002 and Tsc2/ MEFs expressing Raptor shRNA without treatment, or in the presence of LY294002 were subjected
to serum deprivation. Apoptosis was quantified after 48 h of serum deprivation. , P 	 0.001 compared to results for LacZ shRNA; ## and ###,
P 	 0.01 and P 	 0.001, respectively, compared to results for rapamycin; ††, P 	 0.01 compared to results for LY294002; ‡‡‡, P 	 0.001 compared to
results for Raptor shRNA; {, P 	 0.05 compared to results for rapamycin plus LY294002. (E) Akt1 shRNA-mediated abrogation of the increase in Akt
activity induced by rapamycin. Tsc2/ MEFs expressing LacZ shRNA in the absence or presence of rapamycin (20 nM) and Tsc2/ MEFs expressing
Akt1 shRNA in the presence of rapamycin (20 nM) were subjected to serum deprivation for 14 h. Lysates of these cells were analyzed by immunoblotting
using antibodies specific for Akt phosphorylation on Ser473 (an indicator of Akt activity), total Akt1, p70S6 kinase phosphorylation on Thr389 (indicator
of mTORC1 activity), total p70S6 kinase, and actin. (F) Apoptosis induced by the serum deprivation of Tsc2/ MEFs expressing LacZ shRNA in the
absence or presence of rapamycin (20 nM) and Tsc2/ MEFs expressing Akt1 shRNA in the presence of rapamycin (20 nM). The apoptosis was
quantified after 48 h of serum deprivation.  and , P 	 0.01 and P 	 0.001, respectively, compared to results for LacZ shRNA; # and ##, P 	 0.05
and P 	 0.01, respectively, compared to results for Akt1 shRNA. (G) Tsc2/ MEFs were subjected to 75 M etoposide in the presence or absence of
rapamycin (20 nM). Apoptosis was measured after 48 h of serum deprivation. , P 	 0.001 compared to results for etoposide (ETOP); #, P 	 0.05
compared to results for rapamycin (RAPA).
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in the Tsc2/ and Tsc2//Tsc2 MEFs. Unfortunately, the
endogenous BAD could not be detected using available anti-
bodies. Therefore, BAD was retrovirally overexpressed in the
Tsc2/ and Tsc2//Tsc2 MEFs. The examination of the
phosphorylation status of BAD in these cells by immunoblot-
ting using phosphospecific antibodies revealed that in Tsc2/
MEFs, BAD phosphorylation at the Ser136 site is reduced in
the presence or absence of serum compared to that of Tsc2//
Tsc2 MEFs (Fig. 4A). The phosphorylation of BAD on Ser112
was similar between the Tsc2/ and Tsc2//Tsc2 MEFs cul-
tured in the presence of serum, but upon the withdrawal of serum,
the phosphorylation was maintained better in the Tsc2/ MEFs
(Fig. 4A).
To conclusively find out whether inhibitory phosphorylations
of BAD determine the apoptotic response of Tsc2/ MEFs,
these cells and the Tsc2//Tsc2 MEFs were infected with
retroviruses expressing wild-type BAD or a mutated BAD
(Ser112Ala/Ser136Ala) in which the two phosphorylated
serines were mutated to alanines. The cells expressing the
wild-type and mutant BAD proteins were subjected to 6 h of
serum deprivation, which normally, by itself, does not cause
any cell death but is sufficient to unleash the latent apoptotic
potential of BAD. Compared to the Tsc2//Tsc2 MEFs, the
Tsc2/ MEFs exhibit essentially the same degree of apoptotic
resistance to the overexpression of both wild-type BAD and
the mutant BAD(Ser112Ala/136Ala) (Fig. 4B). This suggests
that the increased resistance of Tsc2/ MEFs to serum de-
privation is independent of BAD phosphorylation. These re-
sults also showed that the deficiency of Tsc2 exerts resistance
to apoptosis induced by the overexpression of Bad.
The expression of both HKII and GLUT1 is induced in
serum-deprived Tsc2/ MEFs. Both mitochondrial hexoki-
nases and GLUT1 have been shown to inhibit apoptosis and to
promote growth factor-mediated cell survival (5, 21). We
therefore examined the levels of HKII and GLUT1. We found
that, in contrast to reconstituted Tsc2//Tsc2 MEFs exhibit-
ing decreased GLUT1 abundance following serum depriva-
tion, Tsc2/ MEFs maintained and even increased their
GLUT1 abundance after growth factor withdrawal (Fig. 5A).
In addition, serum withdrawal was associated with a progres-
sive decline in HKII abundance in Tsc2//Tsc2 MEFs,
whereas the corresponding HKII levels not only maintained
but also increased in Tsc2/ MEFs (Fig. 5A). The higher
levels of GLUT1 and HKII in the absence of serum in Tsc2/
MEFs are mTORC1 dependent, because both rapamycin
treatment (Fig. 5A) and Raptor knockdown (Fig. 5B) dimin-
ished their expression.
The increased HKII and GLUT1 expression levels, observed
in Tsc2/ MEFs in the absence of serum, could contribute to
their resistance to serum deprivation-induced apoptosis. To
verify this possibility, HKII and GLUT1 were knocked down
(Fig. 5C), and the ensuing effect on apoptosis induced by
serum deprivation was evaluated (Fig. 5D). The reduction of
the elevated HKII and GLUT1 protein levels in Tsc2/ MEFs
sensitized these cells to apoptosis induced by serum with-
drawal. But even after the knockdown of HKII and GLUT1,
the Tsc2/ MEFs still underwent apoptosis to a lower extent
than the Tsc2//Tsc2 MEFs. Thus, the elevation of HKII and
GLUT1 upon serum deprivation could be an important factor
that determines the resistance of Tsc2/ MEFs to apoptosis
induced by serum withdrawal but may not be the only deter-
minant of their resistance to apoptosis. The knockdown of
HKII alone or GLUT1 alone were not sufficient to sensitize
Tsc2/ MEFs to serum deprivation-induced apoptosis (data
not shown), indicating that in Tsc2/ MEFs both GLUT1 and
HKII are required to promote resistance to growth factor
withdrawal. The elevation of GLUT1 and HKII predominantly
following serum deprivation could explain why Tsc2/ MEFs
are more resistant only to apoptosis induced by the absence of
serum and are not resistant to other apoptotic stimuli in the
presence of serum.
HKII and GLUT1 induction in Tsc2/ MEFs is mediated
by increased HIF1 abundance observed predominately in the
absence of serum. To determine the mechanism by which
GLUT1 and HKII are elevated in Tsc2/ MEFs in the ab-
sence of serum, we first determined GLUT1 and HKII mRNA
expression. A marked increase of GLUT1 mRNA (Fig. 6A) or
HKII mRNA (Fig. 6B) was observed only when Tsc2/ MEFs
were deprived of serum. These results suggest that the eleva-
tion of GLUT1 and HKII proteins is primarily through the
elevation of mRNA. GLUT1 is a known target of hypoxia-
inducible factor 1 (HIF1), and HKII also was shown to be
elevated by HIF1 (14). HIF1 previously was reported to be
elevated in Tsc2/ cells (2). Indeed, as shown in Fig. 6C, we
found a dramatic increase in HIF1 levels in Tsc2/ MEFs,
but unlike previously reported results (2), we found that
HIF1 levels are elevated in Tsc2/ MEFs exclusively in the
absence of serum or following a reduction in serum levels. In
FIG. 4. Resistance of Tsc2/ MEFs to serum withdrawal-induced
apoptosis is independent of BAD phosphorylation. (A) Immunoblot
showing the phosphorylation status of BAD in Tsc2/ or Tsc2//
Tsc2 MEFs overexpressing BAD. The cells were cultured in either
10% serum or 0% serum and in the absence or presence of rapamycin
(20 nM) for 5 h. Lysates of these cells were analyzed by immunoblot-
ting using antibodies specific for BAD phosphorylation on Ser136 or
Ser112 and total BAD. (B) Apoptosis induced by the serum depriva-
tion of Tsc2/ MEFs and Tsc2//Tsc2 MEFs expressing either wild-
type BAD or mutant BAD(Ser112,136Ala). The apoptosis was quan-
tified after 6 h of serum deprivation. Data represent the means 
standard errors of the means from three independent experiments. 
and , P 	 0.05 and P 	 0.01, respectively, compared to results for
Tsc2/ MEFs; #, P 	 0.05 compared to results for BAD.
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the presence of 10% serum, the levels of HIF1 protein in
Tsc2/ cells was comparable to that in control cells. In con-
trast, the basal level of HIF1 protein in Tsc2//Tsc2 MEFs
declined after serum deprivation (Fig. 6C). The elevation of
HIF1 protein following serum deprivation in Tsc2/ MEFs
is dependent on mTORC1, as it is inhibited by rapamycin as
well as by the knockdown of Raptor (Fig. 6D).
To assess the corresponding dependence of increased HKII
and GLUT1 on HIF1, we also knocked down HIF1 in
Tsc2/ MEFs. As shown in Fig. 6E, HIF1 knockdown mark-
edly reduced the induction of GLUT1 and, to a lesser extent,
HKII in serum-deprived Tsc2/ MEFs. Consistently with this,
the knockdown of HIF1 increased the apoptosis of serum-
deprived Tsc2/ MEFs (Fig. 6F) to an extent similar to that
observed following GLUT1 and HKII knockdown (Fig. 5D).
These results suggest that mTORC1-mediated HIF1 eleva-
tion is at least partly responsible for these specific increases in
both HKII and GLUT1 abundance. They also raised the ques-
tion of why these changes in HIF1 abundance and activity are
restricted to serum-deprived Tsc2/ MEFs.
Since our results, in contrast to previous results (2), show
that HIF1 levels and activity are elevated in Tsc2/ MEFs
exclusively after serum deprivation, we wanted to further verify
and substantiate this observation. To identify the mechanism
by which HIF1 is elevated after serum deprivation in Tsc2/
MEFs, we first examined HIF1 mRNA levels in Tsc2/ and
Tsc2//Tsc2 cells in the presence or absence of serum. As
shown in Fig. 6G, mRNAs levels of HIF1 were increased to
the same extent in Tsc2/ and Tsc2//Tsc2 cells following
serum deprivation. However, since mRNA translation medi-
ated by mTORC1 is decreased upon serum deprivation in
Tsc2//Tsc2 cells, it could not yield more HIF1 protein. In
contrast, mTORC1 activity is sustained in Tsc2/ cells follow-
ing serum deprivation, yielding more HIF1 protein. Thus, the
combination of the elevated HIF1 mRNA and the sustained
mRNA translation in Tsc2/ cells in the absence of serum
could explain, at least in part, the elevated HIF1 protein
levels in Tsc2/ cells, particularly in reduced-serum condi-
tions. To verify that the sustained mRNA translation in serum-
deprived Tsc2/ MEFs contributes to elevated HIF1 protein
levels, we exposed the cells to eIF4E ASO, which was shown to
effectively reduce the expression of eIF4E (6). Exposure to
eIF4E ASO diminished the induction of HIF1 protein in
serum-deprived Tsc2/ MEFs (see Fig. 8A).
The sustained inhibition of GSK3 in serum-deprived
Tsc2/ MEFs contributes to their resistance to serum depri-
vation-induced apoptosis. In a search for an additional mech-
anism by which Tsc2/ cells are rendered resistant to serum
deprivation-induced apoptosis, we examined whether the con-
stitutive inhibition of GSK3 in Tsc2/ cells (23) contributes
to their resistance. Normally, GSK3 kinase activity is inhib-
ited by Akt through the phosphorylation of GSK3 on Ser9. In
Tsc2/ MEFs, which exhibit diminished Akt activity, hyper-
active S6K1 can phosphorylate GSK3 and inhibit its activity
even in the absence of serum (23). As such, hyperactive S6K1
can at least partly compensate for the reduced Akt activity
observed in these cells.
In confirmation of this prior finding, we found that in
Tsc2/ MEFs the inhibitory phosphorylation of GSK3 on
Ser9 was sustained even upon serum deprivation, whereas the
Tsc2-proficient MEFs rapidly lost their inhibitory phosphory-
lation of GSK3 when they were placed in the absence of
FIG. 5. Induction of GLUT1 and HKII expression by serum deprivation in Tsc2/ MEFs inhibits apoptosis. (A) Immunoblot showing HKII
and GLUT1 protein levels. Tsc2/ MEFs (lanes 1, 3, 5, 6, 8, 9, and 10) and Tsc2//Tsc2 MEFs (lanes 2, 4, and 7) were cultured in the presence
(lanes 1 and 2) or absence (lanes 3 to 10) of 10% serum and in the presence (lanes 5, 8, and 10) of simultaneous treatment with rapamycin (RAPA;
20 nM) for 14, 18, or 24 h. Lysates of these cells were analyzed by immunoblotting using antibodies specific for HKII, GLUT1, and -actin.
(B) Immunoblot showing the effect of Raptor knockdown on HKII and GLUT1 protein levels. Tsc2/ MEFs expressing either LacZ shRNA
(control) or Raptor shRNA were cultured in the presence or absence of 10% serum for 24 h. Lysates of these cells were analyzed by
immunoblotting using antibodies specific for HKII, GLUT1, and -actin. (C) Immunoblot showing the knockdown of HKII and GLUT1. Tsc2/
MEFs expressing control siRNA and shRNA, Tsc2/ MEFs expressing GLUT1 siRNA and HKII shRNA, and Tsc2//Tsc2 MEFs expressing
control siRNA and shRNA were subjected to serum deprivation for 14 h. Lysates of these cells were analyzed by immunoblotting using antibodies
specific for HKII, GLUT1, and -actin. (D) Effect of HKII and GLUT1 knockdown on apoptosis induced by serum deprivation. The cells described
in panel C were subjected to serum deprivation. Apoptosis was quantified after 24, 34, or 48 h of serum deprivation. Data represent the means 
standard errors of the means from three independent experiments. , , and , P 	 0.05, P 	 0.01, and P 	 0.001, respectively, compared to
results for Tsc2/ MEFs; #, P 	 0.05 compared to results for Tsc2//Tsc2 MEFs.
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serum (Fig. 7A). Active GSK3 can trigger apoptosis via mul-
tiple mechanisms, including the direct phosphorylation of
Mcl-1, leading to its degradation (15), and voltage-dependent
ion channel phosphorylation, leading to hexokinase dissocia-
tion from mitochondria (16). To confirm the contribution of
GSK3 to serum deprivation-induced apoptosis, we deter-
mined the susceptibility of Tsc2//Tsc2 MEFs to apoptosis in
the presence or absence of LiCl, which is a widely used inhib-
itor of GSK3. LiCl partially protected the Tsc2//Tsc2
MEFs from apoptosis induced by serum deprivation (Fig. 7B).
Thus, the constitutive inhibition of GSK3 in the absence of
serum in Tsc2/ cells could partly account for their resistance
to growth factor withdrawal-induced apoptosis.
Sustained Mcl-1 abundance contributes to the resistance of
Tsc2/ MEFs to serum deprivation-induced apoptosis. Mcl-1
is an antiapoptotic member of the Bcl2 family that is normally
downregulated by serum deprivation (15). Because GSK3
inhibition increases Mcl-1 protein stability (15) and because
the translational initiation factor eIF4E, which is activated by
mTORC1, can elevate the translation of Mcl-1 transcripts (22),
we evaluated Mcl-1 abundance in Tsc2/ cells. Unlike recon-
stituted Tsc2//Tsc2 MEFs in which Mcl-1 abundance is sub-
stantially reduced in the absence of serum, Mcl-1 protein levels
were maintained in Tsc2/ MEFs even in the absence of
serum (Fig. 7C). The higher levels of Mcl-1 in serum-deprived
Tsc2/ MEFs reflects sustained mTORC1 activity in these
FIG. 6. Elevation of HIF1 expression in serum-deprived Tsc2/ MEFs mediates the induction of GLUT1 and HKII mRNA expression. (A
and B) Real-time RT-PCR showing GLUT1 (A) and HKII (B) mRNA levels. Tsc2/ MEFs and Tsc2//Tsc2 MEFs were cultured in the
presence or absence of 10% serum with or without simultaneous treatment of rapamycin (RAPA; 20 nM) for 14 h. RNA extracts from these cells
were analyzed by real-time RT-PCR using primers specific for GLUT1, HKII, and actin. The data are represented as the change in GLUT1 or
HKII mRNA levels that were normalized to the actin mRNA levels. *, **, and ***, P 	 0.05, P 	 0.01, and P 	 0.001, respectively, compared
to results for Tsc2/ MEFs; # and ###, P 	 0.05 and P 	 0.001, respectively, compared to results for Tsc2//Tsc2 MEFs. (C) Immunoblot
showing HIF1 protein levels. The upper panel shows Tsc2/ MEFs and Tsc2//Tsc2 MEFs that were cultured in the presence or absence of
10% serum for 14 h. Lysates of these cells were analyzed by immunoblotting using antibodies specific for HIF1 and actin. The lower panel shows
Tsc2/ MEFs that were cultured in the presence of 10, 0.5, 0.1, or 0% serum for 14 h. Lysates of these cells were analyzed by immunoblotting
using antibodies specific for HIF1 and actin. (D) Immunoblot showing the effect of mTORC1 inhibition on HIF1 expression. Tsc2/ MEFs
in the absence or presence of rapamycin (20 nM) and Tsc2/ MEFs expressing LacZ shRNA (control) or Raptor shRNA were cultured in the
presence or absence of 10% serum for 24 h. Lysates of these cells were analyzed by immunoblotting using antibodies specific for HIF1 and actin.
(E) The knockdown of HIF1 reduced the expression of HKII and GLUT1 in serum-deprived Tsc2/ MEFs. Tsc2/ MEFs expressing either
control siRNA or HIF1 siRNA and Tsc2//Tsc2 MEFs expressing control siRNA were subjected to serum deprivation for 14 h. Lysates of these
cells were analyzed by immunoblotting using antibodies specific for HIF1, HKII, GLUT1, and tubulin. (F) Tsc2/ MEFs expressing either
control siRNA or HIF1 siRNA and Tsc2//Tsc2 MEFs expressing control siRNA were subjected to serum deprivation for 34 h, and then
apoptosis was assessed by DAPI staining. Data represent the means  standard errors of the means from three independent experiments. ** and
***, P 	 0.01 and P 	 0.001 compared to results for Tsc2
/ MEFs; ##, P 	 0.01 compared to results for Tsc2//Tsc2 MEFs. (G) HIF1 mRNA
is induced in the absence of serum. Tsc2/ MEFs and Tsc2//Tsc2 MEFs were cultured in the presence of 10 or 0% FBS for 14 h. RNA extracts
from these cells were analyzed by real-time RT-PCR using primers specific for HIF1 and actin. The data are represented as the change in HIF1
mRNA levels that were normalized to the actin mRNA levels. * and ***, P 	 0.05 and P 	 0.001, respectively, compared to results for Tsc2
/
MEFs; ###, P 	 0.001 compared to results with 10% FBS.
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cells, as both rapamycin and Raptor knockdown reduced Mcl-1
abundance in these cells (Fig. 7D). This sustained Mcl-1 ex-
pression following growth factor withdrawal also contributes to
the apoptotic resistance of serum-deprived Tsc2/ MEFs.
Importantly, Mcl-1 abundance remained equivalent in both
Tsc2/ and Tsc2//Tsc2 MEFs in the presence of serum. As
such, Mcl-1 probably confers no antiapoptotic advantages to
Tsc2/ cells in the presence of serum. To verify the contri-
bution of sustained mRNA translation in serum-deprived
Tsc2/ MEFs to the sustained level of Mcl-1 protein, we
exposed the cells to eIF4E ASO and found that Mcl-1 protein
expression was diminished (Fig. 8A). Thus, both mRNA trans-
lation and GSK3 inhibition in serum-deprived Tsc2/ MEFs
could contribute to the sustained Mcl-1 protein level.
To determine whether sustained Mcl-1 expression contrib-
utes to the apoptotic resistance of serum-deprived Tsc2/
cells, we examined the consequences of Mcl-1 knockdown in
these cells (Fig. 7E). The knockdown of Mcl-1 in Tsc2/
MEFs reduced the levels of Mcl-1 to approximately the same
levels observed in Tsc2//Tsc2 MEFs in the absence of serum.
As shown in Fig. 7F, the knockdown of Mcl-1 increased the
sensitivity of Tsc2/ MEFs to growth factor withdrawal-in-
duced apoptosis, indicating that the sustained expression of
Mcl-1 protein in the absence of serum in Tsc2/ MEFs con-
tributes to their resistance to apoptosis. The increase in apop-
tosis after Mcl-1 knockdown is reduced in the presence of LiCl,
with a concomitant increase in Mcl-1 protein levels (Fig. 8B
and C). The overexpression of GLUT1 has been reported to
maintain Mcl-1 protein levels upon growth factor withdrawal.
This is because increased glycolysis causes the activation of
FIG. 7. Sustained inhibition of GSK3 and the continuous expression of Mcl-1 in serum-deprived Tsc2/ MEFs contribute to their resistance
to apoptosis. (A) Immunoblot showing the inhibitory phosphorylation of GSK3 (p-GSK3) in Tsc2/ MEFs and Tsc2//Tsc2 MEFs. The cells
were cultured in the presence or absence of 10% serum for 14 h, and lysates of these cells were immunoblotted for the detection of the inhibitory
phosphorylation of GSK3 on Ser9 as well as the total GSK3 levels. (B) Effect of lithium chloride (a GSK3 inhibitor) on apoptosis induced by
serum deprivation. Tsc2/ MEFs and Tsc2//Tsc2 MEFs in the absence or presence of LiCl (10 mM) were subjected to serum deprivation for
34 h, and the resulting apoptosis was measured. , P 	 0.05 compared to results for Tsc2/ MEFs; ##, P 	 0.01 compared to results for
Tsc2//Tsc2 MEFs. (C) The panel on the left is an immunoblot showing Mcl-1 expression in Tsc2/ and Tsc2//Tsc2 MEFs. The cells were
cultured in the presence or absence of 10% serum for 14 h, and lysates of these cells were immunoblotted for the detection of Mcl-1 and -actin.
The panel on the right shows the quantification of these immunoblotting results, represented as the change in Mcl-1 protein levels that were
normalized to the -actin protein levels. (D) The panel on the left is an immunoblot showing the effect of mTORC1 inhibition on Mcl-1 expression.
Tsc2/ MEFs in the absence or presence of rapamycin (RAPA; 20 nM) and Tsc2/ MEFs expressing LacZ shRNA (control) or Raptor shRNA
were cultured in the presence or absence of 10% serum for 24 h. Lysates of these cells were immunoblotted for the detection of Mcl-1 and -actin.
The panel on the right shows the quantification of these immunoblotting results, represented as the change in Mcl-1 protein levels that were
normalized to the -actin protein levels. (E) Immunoblot showing the knockdown of Mcl-1. Tsc2/ MEFs expressing control siRNA or Mcl-1
siRNA and Tsc2//Tsc2 MEFs expressing control siRNA were cultured in the presence or absence of 10% serum and with or without
simultaneous rapamycin (20 nM) treatment for 14 h. Lysates of these cells were immunoblotted for the detection of Mcl-1 and -actin. (F) Effect
of Mcl-1 knockdown on apoptosis induced by serum deprivation. The cells described in panel E were subjected to serum deprivation for 24, 34,
or 48 h, and the resulting apoptosis was quantified. Data represent the means  standard errors of the means from three independent experiments.
, , and , P 	 0.05, P 	 0.01, and P 	 0.001 compared to results for Tsc2/ MEFs; #, P 	 0.05 compared to results for Tsc2//Mcl-1 siRNA.
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protein kinase C, which can phosphorylate and thereby inhibit
GSK3 (24). However, we found the maintenance of GSK3
inhibitory phosphorylation as well as the maintenance of Mcl-1
levels in the Tsc2/ MEFs even upon knockdown of GLUT1
and HKII (data not shown). This difference could reflect the
ability of hyperactive eIF4E to maintain Mcl-1 mRNA trans-
lation and the hyperactive S6K1 to phosphorylate GSK3 in
Tsc2/ MEFs even after HKII and GLUT1 are reverted to
wild-type levels. Thus, there are two independent reasons for
the resistance of Tsc2/ MEFs to serum withdrawal: in-
creased HKII and GLUT1 abundance and the maintenance of
Mcl-1 expression.
HKII and GLUT1 abundance is dependent on HIF1. The
high levels of both HIF1 and Mcl-1 proteins in serum-de-
prived Tsc2/ MEFs are dependent largely on the sustained
mRNA translation. Therefore, it is expected that the inhibition
of the sustained mRNA translation in serum-deprived Tsc2/
MEFs abrogates their resistance to apoptosis. Indeed, the ex-
posure of Tsc2/ MEFs to eIF4E ASO overcame their resis-
tance to serum deprivation-induced apoptosis (Fig. 8D).
DISCUSSION
Akt is a major downstream effector of growth factor-medi-
ated cell survival in mammalian cells, and its activation inhibits
apoptosis induced by diverse proapoptotic stimuli. It therefore
is expected that cells with reduced Akt activity will be sensi-
tized to apoptosis. Tsc1/2-deficient cells exhibit low Akt activity
due to mTORC1 hyperactivation and negative regulatory feed-
back to inhibit Akt activity in these cells (reviewed in reference
1). As expected, Tsc1/2-deficient cells have been shown to be
hypersensitive to apoptotic stimuli such as exposure to etopo-
FIG. 8. Reduced level of eIF4E diminishes Mcl-1 and HIF1 protein expression in serum-deprived Tsc2/ MEFs and abrogates the resistance
of Tsc2/ MEFs to serum deprivation-induced apoptosis. (A) The left panel is an immunoblot showing the effect of the eIF4E ASO on Mcl-1
and HIF1 expression in the absence of FBS. Tsc2/ MEFs were transfected with control (Cont.) or eIF4E ASOs, and then 48 h after transfection
these cells were subjected to serum withdrawal for 72 h. Lysates of these cells were immunoblotted for the detection of eIF4E, Mcl-1, HIF1, and
-actin. The panels on the right show the quantification of these immunoblotting results, represented as the changes in Mcl-1 and HIF1 protein
levels normalized to the -actin protein levels. (B) Tsc2/ MEFs expressing control siRNA or Mcl-1 siRNA and Tsc2//Tsc2 MEFs expressing
control siRNA were cultured in the absence of serum and with or without simultaneous LiCl (10 mM) treatment for 34 h, and the resulting
apoptosis was quantified. Data represent the means  standard errors of the means from three independent experiments. , , and , P 	 0.05,
P 	 0.01, and P 	 0.001, respectively, compared to results for Tsc2/ MEFs; # and ##, P 	 0.05 and P 	 0.01, respectively, compared to results
for Tsc2//Tsc2 MEFs; †, P 	 0.05 compared to results for Tsc2//Tsc2 MEFs plus LiCl; and ‡, P 	 0.05 compared to results for Mcl-1 siRNA.
(C) Immunoblot showing the knockdown of Mcl-1. Cells were treated as described for panel B for 14 h. Lysates of these cells were immunoblotted
for the detection of Mcl-1, phosphorylated GSK3 (p-GSK3), GSK3/, and -tubulin. (D) Apoptosis induced by eIF4E ASO in the absence
of FBS. Quantification of apoptosis in the cells described for panel A. Data represent the means  standard errors of the means from three
independent experiments. (E) Schematic illustration summarizing the sequence of events that mediate resistance to serum deprivation-induced
apoptosis by hyperactive mTORC1 in Tsc-deficient cells. In the absence of serum, hyperactive mTORC1 increases the abundance of HIF1, which
in turn elevates the expression of HKII and GLUT1 to inhibit apoptosis. The increase in HIF1 expression is dependent largely on the elevated
eIF4E activity in Tsc-deficient cells. In parallel, the elevation of S6K1 and eIF4E activities by the hyperactive mTORC1 maintain the expression
of Mcl-1 in the absence of serum by two different mechanisms. eIF4E increases Mcl-1 protein synthesis, and the inhibition of GSK3 activity by S6K1
increases the stability of Mcl-1 protein. In addition, the inhibition of GSK3 may accelerate the ability of HKII to inhibit apoptosis.
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side, methyl methanesulfonate (MMS), doxorubicin, stauro-
sporine, and glucose deprivation (4, 8, 19) (Fig. 1). How-
ever, as demonstrated herein, Tsc1/2-deficient cells are
extremely resistant to growth factor deprivation-induced ap-
optosis, and hyperactive mTORC1 signaling is a major con-
tributor to this phenomenon. Importantly, however, the in-
hibition of mTORC1 does not cause robust sensitization to
growth factor deprivation-induced apoptosis because of the
concomitant increase in Akt activity. Notably, the inhibition of
mTORC1 by rapamycin modestly or did not sensitize cells to
apoptosis, whereas Raptor knockdown actually protected the
cells from apoptosis (Fig. 3A). This difference most likely is
due to the fact that although both rapamycin and Raptor
knockdown caused a similar inhibition of mTORC1, the
knockdown of Raptor triggered a much higher increase in the
Ser473 phosphorylation of Akt than did rapamycin treatment
(Fig. 3B). However, the resistance to apoptosis appears to be
due largely to the hyperactive eIF4E downstream of the
hyperactive mTORC1 in serum-deprived Tsc2/ cells.
Consistently reduced eIF4E expression abrogates the resis-
tance of Tsc2/ cells to serum deprivation-induced apo-
ptosis (Fig. 8D).
We found several mechanisms, depicted in Fig. 8E, by which
the hyperactive mTORC1 in Tsc-deficient cells provides the
inhibition of apoptosis in the absence of growth factors. We
showed that the expression of HKII is elevated following the
serum deprivation of Tsc2/ cells, whereas in control cells its
expression slightly declines. Likewise, the expression of
GLUT1 also is elevated in Tsc2/ cells upon serum depriva-
tion. The overexpression of mitochondrial hexokinases alone
(5) or in combination with GLUT1 (17) was shown to pheno-
copy growth factor- or Akt-mediated cell survival. Indeed, we
have demonstrated that the combined elevation of HKII and
GLUT1 expression in the absence of serum in Tsc2/ cells
contributes to their resistance to apoptosis. In the presence of
serum, the levels of HKII and GLUT1 are similar in Tsc2/
and control cells, and therefore under these conditions
Tsc2/ cells are more sensitive to apoptosis because of the
lower Akt activity. Notably, the higher Akt activity in control
cells may mediate cell survival by increasing HKII-mitochon-
dria interaction (5).
The finding that increased HKII and GLUT1 abundance
was observed exclusively in serum-deprived Tsc2/ cells was
somewhat surprising, but this can be attributed to correspond-
ing increases in HIF1 abundance under these conditions. The
fact that the observed increases in HIF1 abundance and ac-
tivity also are restricted to serum-deprived Tsc2/ MEFs also
is intriguing and can be explained by the combination of
HIF1 mRNA induction and constitutive mRNA translation
observed in these cells. This is supported by our observation
that the increase in HIF1 abundance in serum-deprived
Tsc2/ MEFs is reduced by eIF4E ASO (Fig. 8A).
An additional contributor to the apoptotic resistance of
Tsc2/ cells to growth factor withdrawal involves sustained
GSK3 inhibition under these conditions. In control cells, GSK3
normally is activated upon growth factor withdrawal, reflecting
decreased inhibition by Akt. However, inhibitory GSK3 phos-
phorylation is maintained in Tsc2/ cells even in the absence
of serum due to the phosphorylating capacity of constitutively
active S6K1 in these cells (23). GSK3 can affect apoptotic
susceptibility by multiple mechanisms. For example, it has
been shown that interaction between HKII and VDAC at the
outer mitochondrial membrane promotes cell survival (5, 12,
13). GSK3 activation has been reported to disrupt this inter-
action and thereby increase apoptosis (16). Thus, elevated
HKII expression in serum-deprived Tsc2/ cells also should
have the preserved capacity to physically and functionally in-
teract with mitochondria (reviewed in reference 19).
Another consequence of constitutive GSK3 inhibition in se-
rum-deprived Tsc2/ cells involves the maintenance of high
levels of the antiapoptotic Bcl2 family member Mcl-1, which
normally declines rapidly following serum withdrawal. As pre-
viously demonstrated, the phosphorylation of Mcl-1 by GSK3
targets Mcl-1 for degradation (15). As such, GSK3 inhibition
could explain, in part, why Mcl-1 abundance is not diminished
by serum withdrawal in these cells. However, its short half-life
makes Mcl-1 abundance very sensitive to changes in mRNA
translation. Indeed, it has been shown that the translation
initiation factor eIF4E increases Mcl-1 abundance in the pres-
ence of serum (22). Since eIF4E also is hyperactive in Tsc2/
cells, even in the absence of serum, this could contribute to the
sustained Mcl-1 expression observed in these cells. This is
supported by our observation that Mcl-1 abundance is dimin-
ished in serum-deprived Tsc2/ MEFs after exposure to
eIF4E ASO (Fig. 8A).
Although Tsc2/ cells are highly resistant to apoptosis
caused by serum deprivation, as indicated above, they are more
sensitive to apoptotic stimuli like DNA damage and stauro-
sporine. The increased sensitivity of Tsc2/ cells to apoptotic
stimuli is probably a consequence of reduced Akt activity in
these cells. Serum withdrawal reduces Akt activity in both the
Tsc2/ and control cells, but unlike control cells, which lose
their mTORC1 activity under these conditions, Tsc2/ MEFs
maintain their mTORC1 activity, and this is responsible for
their resilience in terms of apoptosis. Notably, the increased
resistance of Tsc2/ cells to serum deprivation is not sufficient
to exert increased resistance to etoposide or staurosporine
under these conditions (Fig. 1I and J). Perhaps the mecha-
nisms that promote the resistance of Tsc2/ cells to serum
deprivation cannot withstand serum deprivation combined
with other apoptotic stimuli. This binary apoptotic response of
Tsc2/ MEFs also may help explain the relatively benign
nature of tuberous sclerosis-associated hamartomas. Reduced
Akt activity is unlikely to attenuate cell proliferation in these
tumors, because we have shown previously that hyperactive
mTORC1 can compensate for Akt deficiency with regard to
cell proliferation and oncogenic transformation (20). We pro-
pose that the binary apoptotic response caused by Tsc1/2 in-
activation is at least partly responsible for the nonmalignant
nature of tuberous sclerosis-associated hamartomas. Although
the resistance of Tsc2/ cells to growth factor limitation
would promote tumor progression, the marked sensitivity of
these cells to other cellular stresses would serve to counteract
these effects and thereby limit tumor growth in vivo. As such,
our findings provide additional insights into the genesis of the
hamartomas in tuberous sclerosis. They suggest that mTORC1
hyperactivity drives hamartoma formation not only through
increased cell proliferation but also by promoting cell survival
under conditions of growth factor limitation. Although
mTORC1 inhibition failed to cause robust sensitization to
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growth factor deprivation-induced apoptosis because of con-
comitant increases in Akt activity, the combination of
mTORC1 inhibition and partial Akt antagonism (to counteract
the increase in Akt activity caused by mTORC1 inhibition)
proved more effective. This observation has major therapeutic
implications for the treatment of tuberous sclerosis, since it
suggests that rapamycin analogues alone are unlikely to be
efficacious in treating tuberous sclerosis unless they are com-
bined with Akt inhibitors. In contrast, specific inhibitors of
eIF4E by themselves, such as eIF4E ASO, could be effective in
treating tuberous sclerosis.
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